CDCA7L expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison | Statistical significance |
Normal-vs-Primary | 3.53539975073147E-10 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
5.94889999999682E-05 |
Normal-vs-Stage2 |
3.397400E-03 |
Normal-vs-Stage3 |
N/A |
Normal-vs-Stage4 |
1.760350E-03 |
Stage1-vs-Stage2 |
8.411800E-01 |
Stage1-vs-Stage3 |
N/A |
Stage1-vs-Stage4 |
5.037000E-01 |
Stage2-vs-Stage3 |
N/A |
Stage2-vs-Stage4 |
3.766000E-01 |
Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
2.96159996526768E-09 |
Normal-vs-AfricanAmerican |
4.356400E-01 |
Normal-vs-Asian |
9.699600E-02 |
Caucasian-vs-AfricanAmerican |
7.475000E-01 |
Caucasian-vs-Asian |
6.067800E-01 |
AfricanAmerican-vs-Asian |
5.102000E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
4.15540000000547E-05 |
Normal-vs-Female |
1.5054599999953E-05 |
Male-vs-Female |
7.859600E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
6.157200E-04 |
Normal-vs-Extreme_Weight |
6.29749999999651E-05 |
Normal-vs-Obese |
1.178090E-02 |
Normal-vs-Extreme_Obese |
N/A |
Normal_Weight-vs-Extreme_Weight |
9.883800E-01 |
Normal_Weight-vs-Obese |
8.757400E-01 |
Normal_Weight-vs-Extreme_Obese |
N/A |
Extreme_Weight-vs-Obese |
8.646400E-01 |
Extreme_Weight-vs-Extreme_Obese |
N/A |
Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.766600E-01 |
Normal-vs-Age(41-60Yrs) |
1.002030E-03 |
Normal-vs-Age(61-80Yrs) |
1.33000000002159E-06 |
Normal-vs-Age(81-100Yrs) |
3.562800E-01 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.461200E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.834200E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.099000E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.113800E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.668400E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.828160E-01 |
|
|
CHOL : Cholangiocarcinoma
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
N/A |
Normal-vs-Grade 2 |
6.448200E-01 |
Normal-vs-Grade 3 |
6.876000E-01 |
Normal-vs-Grade 4 |
1.000000E+00 |
Grade 1-vs-Grade 2 |
N/A |
Grade 1-vs-Grade 3 |
N/A |
Grade 1-vs-Grade 4 |
N/A |
Grade 2-vs-Grade 3 |
8.824600E-01 |
Grade 2-vs-Grade 4 |
6.448200E-01 |
Grade 3-vs-Grade 4 |
6.876000E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
3.76689999970203E-07 |
Normal-vs-N1 |
6.380200E-03 |
N0-vs-N1 |
1.456230E-01 |
|
|